[The Clinical Analysis of Plakophilin-2 Gene Mutation in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia].

Xin Liu,Wenling Liu,Dayi Hu,Li Zhang,Tiangang Zhu,Cuilan Li,Xiaoliang Qiu,Lei Li,Chengjun Guo,Xingpeng Liu,Lei Wang,Hua Zheng,Chunling Wang,Qing Diao,Dan Shi,Pingyun Zhan,Yuanming Deng,Kunshen Liu,Yi Wang,Baomin Liu,Hongming Liu,Xuguang Qin,Yanping Lan

2015-01-01

Abstract:OBJECTIVE:The purpose of this study was to screen genetic variations in plakophilin-2 (PKP2) gene in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) and investigate the differences in clinical features between mutation and no-mutation groups.METHODS:Thirty unrelated Chinese patients clinically diagnosed with ARVC/D and 50 healthy controls were included. Genomic DNA was isolated from peripheral blood samples. PCR and direct sequencing were used to detect variations in PKP2 gene.RESULTS:Eight PKP2 mutant variants were identified in 10 ARVC/D patients (8 men, 2 women). Among the eight mutation, three (c.2194C>T, c. 1170+ 1G>A and c. 810_813delGGTC) were novel mutation. Clinical features of the PKP2 mutation group were similar to those of the non-mutation group.CONCLUSIONS:The rate of PKP2 mutation is 33.3% (10/30) in ARVC/D patients. The penetrance of PKP2 mutation for ARVC/D tends to be higher in man patients. No significant differences could be detected in phenotype characteristics between patients with and without PKP2 mutation.